Literature DB >> 12967600

A possible cardioprotective effect of heat shock proteins during cardiac surgery in pediatric patients.

Daniela Giannessi1, Chiara Caselli, Rosa Letizia Vitale, Adrian Crucean, Bruno Murzi, Silvia Del Ry, Vittorio Vanini, Andrea Biagini.   

Abstract

BACKGROUND: Overexpression of heat shock proteins (Hsps) is associated to myocardial protection and it has been suggested that they could be a marker of cardiac preservation in conditions such as extracorporeal circulation. Aim of this study was to evaluate if cardioplegic arrest can modify the expression of Hsps in the heart and if this alteration is associated to cardiac preservation.
METHOD: The levels of Hsp 27, Hsp 60, and both the constitutive and the inducible form of Hsp 70 were measured in the cardiac tissue from right atrium of pediatric patients before and after aortic cross-clamping (ACC) during cardiopulmonary bypass surgery for correction of congenital heart disease (n=20). The quantitative evaluation of Hsps was made by Western blotting analysis after tissue extraction and protein separation. Hsp 72 mRNA expression was also evaluated in pre- and post-ACC samples of eight subjects by semiquantitative RT-PCR. Peripheral levels of Troponin I, Myoglobin, LDH, CK, CK-MB were measured in basal conditions and at 12 and 24h after cardiosurgery as markers of heart damage.
RESULTS: The cardioplegic arrest did not significantly modify the mean levels of all the Hsps measured. Hsp 72 levels increased after cardioplegia in the 40% of the patients and all Hsps in the 28% of subjects. The patients whose levels of Hsps are increased after cardioplegia are associated with lower post-surgery concentrations of all the markers of cardiac injury.
CONCLUSIONS: This observation suggests a relationship between the increase of Hsps and the reduction of cardiac injury.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12967600     DOI: 10.1016/s1043-6618(03)00193-2

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  6 in total

1.  Ectoine from halophilic microorganisms induces the expression of hsp70 and hsp70B' in human keratinocytes modulating the proinflammatory response.

Authors:  Elisabetta Buommino; Chiara Schiraldi; Adone Baroni; Iole Paoletti; Monica Lamberti; Mario De Rosa; Maria Antonietta Tufano
Journal:  Cell Stress Chaperones       Date:  2005       Impact factor: 3.667

Review 2.  Blood Versus Crystalloid Cardioplegia in Pediatric Cardiac Surgery: A Systematic Review and Meta-analysis.

Authors:  Konstantinos S Mylonas; Aspasia Tzani; Panagiotis Metaxas; Dimitrios Schizas; Vasileios Boikou; Konstantinos P Economopoulos
Journal:  Pediatr Cardiol       Date:  2017-09-25       Impact factor: 1.655

Review 3.  Hsp70 and cardiac surgery: molecular chaperone and inflammatory regulator with compartmentalized effects.

Authors:  Petrus R de Jong; Alvin W L Schadenberg; Nicolaas J G Jansen; Berent J Prakken
Journal:  Cell Stress Chaperones       Date:  2008-07-31       Impact factor: 3.667

4.  Polydatin, a natural precursor of resveratrol, induces β-defensin production and reduces inflammatory response.

Authors:  Giampietro Ravagnan; Anna De Filippis; Maria Cartenì; Salvatore De Maria; Valentina Cozza; Marcella Petrazzuolo; Maria Antonietta Tufano; Giovanna Donnarumma
Journal:  Inflammation       Date:  2013-02       Impact factor: 4.092

5.  Acute Changes in Myocardial Expression of Heat Shock Proteins and Apoptotic Response Following Blood, delNido, or Custodiol Cardioplegia in Infants Undergoing Open-Heart Surgery.

Authors:  Eylem Yayla-Tunçer; Aslıhan Şengelen; Berra Zümrüt Tan-Recep; Ömer Faruk Şavluk; Abdullah Arif Yilmaz; Hakan Ceyran; Evren Önay-Uçar
Journal:  Pediatr Cardiol       Date:  2021-10-25       Impact factor: 1.655

6.  Custodiol HTK versus Plegisol: in-vitro comparison with the use of immature (H9C2) and mature (HCM) cardiomyocytes cultures.

Authors:  Rafał Nowicki; Mikołaj Berezowski; Julita Kulbacka; Katarzyna Bieżuńska-Kusiak; Marek Jasiński; Jolanta Saczko
Journal:  BMC Cardiovasc Disord       Date:  2022-03-17       Impact factor: 2.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.